| Ellis SG, Tendera M, de Belder MA, et al.
1-Year Survival in a Randomized Trial of Facilitated Reperfusion Results From the FINESSE (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events) Trial. [Journal Article]
JACC Cardiovasc Interv 2009 Oct; 2(10):909-16.
Abstract | Full Citation | Find Related Articles | | Bertrand OF, Rodés-Cabau J, Rinfret S, et al.
Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy. [Journal Article, Research Support, Non-U.S. Gov't]
Am J Cardiol 2009 Nov 1; 104(9):1235-40.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dommke C, Turschner O, Stassen JM, et al.
Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis. [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Oct 16.
Abstract | Full Citation | Find Related Articles | | Mikkilineni H, Bruhl SR, Colyer WR, et al.
A retrospective analysis and case series of glycoprotein IIb/IIIa inhibitor associated diffuse alveolar hemorrhage: two case reports. [Journal Article]
Cases J 2009.:8553.
Abstract | Full Citation | | Capodanno D, Prati F, Pawlowsky T, et al.
ClearWayRX System to reduce intracoronary thrombus in patients with acute coronary syndromes according to Optical Coherence Tomography after Abciximab Intracoronary Local infusion trial (COCTAIL): study rationale and design. [JOURNAL ARTICLE]
J Cardiovasc Med (Hagerstown) 2009 Oct 13.
Abstract | Full Citation | | Barua RS, Sy F, Srikanth S, et al.
Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure. An Ex Vivo Investigation. [JOURNAL ARTICLE]
Arterioscler Thromb Vasc Biol 2009 Oct 8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Choi DH, Suh JW, Park KW, et al.
Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: a prospective, open-label, randomized, controlled study in Korean patients. [Journal Article]
Clin Ther 2009 Aug; 31(8):1804-11.
Abstract | Full Citation | | Basalus M, Louwerenburg JW, van Houwelingen KG, et al.
Primary percutaneous coronary intervention in the left main stem of a monocoronary artery. [Journal Article]
Neth Heart J 2009 Aug; 17(7-8):274-6.
Abstract | Full Citation | | Szabo S, Etzel D, Walter T, et al.
Abciximab combined with half-dose reteplase has beneficial effects on inflammatory myocardial response in patients with myocardial infarction. [Journal Article]
Blood Coagul Fibrinolysis 2009 Mar; 20(2):129-33.
Abstract | Full Citation | Find Related Articles | | Gu YL, Fokkema ML, Kampinga MA, et al.
Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. [JOURNAL ARTICLE]
Trials 2009 Sep 28; 10(1):90.
Abstract | Full Citation | Find Related Articles |    |
|
| |
Advertise on this site.
|
